The concept of broadcasting had its roots in a form of the telephone: a technique of narrowcasting where wealthy people could subscribe to have a second telephone line connected to their home.


The concept of broadcasting had its roots in a form of the telephone: a technique of narrowcasting where wealthy people could subscribe to have a second telephone line connected to their home.

The designers, engineers, and computer scientists we teach today will shape the systems of tomorrow–we need to teach them to center justice, not just solve problems.

When AI algorithms fail or deviate from their intended outcomes, resulting in negative impacts on society, they themselves cannot be held accountable since they are not moral agents. Although engineers may not be the sole owners of a language model, their involvement in the chain of operation requires a sense of collaborative accountability.

Aligning design with collective care refocuses requirements for development toward safety, accountability, and the real networks that deliver care. Until the design of digital technologies matches the accessibility and reliability of the paperbased binder system, the binder remains the more ethical coordination tool for communication and continuity in complex home care.

Since many forms of lifestyle monitoring are “untraditional”—that is to say, they are novel, often experimental, and do not track hard quantifiable biomedical parameters—it is perhaps unsurprising that few options exist to defray costs for older adults and their care partners.

Calling something intelligent, even artificially intelligent, ever so subtly implies that it is more than just a thing, more than a tool. And yet, that is precisely what AI is: a tool, a thing.

FDA’s benefit–Risk assessment is an integrated judgment about the meaningfulness of benefit, the acceptability of risk, and the tolerance of uncertainty. But no matter how well clinical evaluations are designed and implemented, some remaining uncertainty about a drug’s benefits and risks is inevitable at the time of a new drug approval decision because of the inherent limitations of clinical trials.

Whereas artificial intelligence and technological innovation continue to be heralded as producing ground-breaking advancements in society, the question of whether they will break free from Western technology’s cultural hegemony remains to be seen.

Opting in to the tech we want and need means being intentional with technology choices and time.